Fisher Patrick sold $1K of OFIX
Fisher Patrick (President, Global Limb Recon) sold 150 shares of Orthofix Medical Inc. (OFIX) at $9.07 on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is small relative to total holdings and executed under a 10b5‑1 plan, suggesting limited new information for traders.
Market read
A routine insider sale with modest size; unlikely to move the stock significantly.
What to watch
Potential upcoming corporate actions or clinical trial news not disclosed in this filing.
Background
Form 4 filings disclose insider transactions and are primary sources for such events.
Ticker impact
President Fisher Patrick sold 150 shares of Orthofix Medical (OFIX) for $1,360.50 via a 10b5‑1 plan.
likely modest pressure as the market prices in the insider sell
The sale is modest in size relative to holdings and uses a pre‑arranged plan, limiting informational value.
Market effects
Minimal impact on the medical device sector; typical insider sales are routine.
No discernible regional effect.
Low relevance to broader markets.
Counterpoint
The sale could be unrelated to company fundamentals and merely portfolio rebalancing.
Key entities
- OfficerFisher Patrick
President, Global Limb Recon at Orthofix Medical


